Balanced discussion of second-generation antihistamines' data.
作者信息
Boev Rossen, Bentz Jürgen Wg
机构信息
UCB Pharma, Bulle, Switzerland.
UCB Pharma, Brussels, Belgium.
出版信息
Ther Clin Risk Manag. 2016 Nov 24;12:1777-1781. doi: 10.2147/TCRM.S124148. eCollection 2016.
Abstract
摘要
相似文献
1
Balanced discussion of second-generation antihistamines' data.第二代抗组胺药数据的均衡讨论。
Ther Clin Risk Manag. 2016 Nov 24;12:1777-1781. doi: 10.2147/TCRM.S124148. eCollection 2016.
2
Non-sedating antihistamines in the treatment of chronic idiopathic urticaria using patient-reported outcomes.使用患者报告结局评估非镇静性抗组胺药治疗慢性特发性荨麻疹的疗效
Curr Med Res Opin. 2008 Aug;24(8):2423-8. doi: 10.1185/03007990802243895. Epub 2008 Jul 22.
3
The Use of a Poisson Regression to Evaluate Antihistamines and Fatal Aircraft Mishaps in Instrument Meteorological Conditions.使用泊松回归评估抗组胺药与仪表气象条件下的致命飞机事故
Aerosp Med Hum Perform. 2018 Apr 1;89(4):389-395. doi: 10.3357/AMHP.4828.2018.
4
Second-generation H1-antihistamines in chronic urticaria: an evidence-based review.第二代 H1 抗组胺药在慢性荨麻疹中的应用：基于证据的综述。
Am J Clin Dermatol. 2011 Dec 1;12(6):361-76. doi: 10.2165/11591130-000000000-00000.
5
More questions than answers: antihistamines' link to cancer.问题多于答案：抗组胺药与癌症的关联
CMAJ. 1994 Sep 15;151(6):797-801.
6
7
Knowledge and Attitude of Medical Resident Doctors Toward Antihistamines.住院医师对抗组胺药的认知与态度
Indian J Dermatol. 2015 Nov-Dec;60(6):635. doi: 10.4103/0019-5154.169141.
8
Differential thermodynamic driving force of first- and second-generation antihistamines to determine their binding affinity for human H1 receptors.第一代和第二代抗组胺药的差异热力学驱动力以确定它们对人H1受体的结合亲和力。
Biochem Pharmacol. 2014 Sep 15;91(2):231-41. doi: 10.1016/j.bcp.2014.07.015. Epub 2014 Jul 24.
9
H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.H1抗组胺药：反向激动作用、抗炎作用及心脏效应。
Clin Exp Allergy. 2002 Apr;32(4):489-98. doi: 10.1046/j.0954-7894.2002.01314.x.
10
Why are second-generation H1-antihistamines minimally sedating?为什么第二代H1抗组胺药的镇静作用极小？
Eur J Pharmacol. 2015 Oct 15;765:100-6. doi: 10.1016/j.ejphar.2015.08.016. Epub 2015 Aug 17.
本文引用的文献
1
Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine.过敏性鼻炎和荨麻疹的治疗：新型抗组胺药物比拉斯汀综述
Ther Clin Risk Manag. 2016 Apr 13;12:585-97. doi: 10.2147/TCRM.S105189. eCollection 2016.
2
Safety and tolerability of bilastine 10 mg administered for 12 weeks in children with allergic diseases.10毫克比拉斯汀对过敏性疾病儿童给药12周的安全性和耐受性
Pediatr Allergy Immunol. 2016 Aug;27(5):493-8. doi: 10.1111/pai.12555. Epub 2016 May 5.
3
Comparative efficacy of non-sedating antihistamine updosing in patients with chronic urticaria.非镇静性抗组胺药增量给药对慢性荨麻疹患者的疗效比较
World Allergy Organ J. 2014 Nov 26;7(1):33. doi: 10.1186/1939-4551-7-33. eCollection 2014.
4
Up-dosing with bilastine results in improved effectiveness in cold contact urticaria.加倍剂量的比拉斯汀可改善冷接触性荨麻疹的疗效。
Allergy. 2013 Jul;68(7):921-8. doi: 10.1111/all.12171. Epub 2013 Jun 6.
5
Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitis.比拉斯汀 20 毫克与西替利嗪 10 毫克和安慰剂治疗常年性变应性鼻炎的疗效和安全性比较。
Curr Med Res Opin. 2012 Jan;28(1):121-30. doi: 10.1185/03007995.2011.640667. Epub 2011 Nov 30.
6
The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.左西替利嗪和地氯雷他定在常规剂量的 4 倍治疗难治性荨麻疹的疗效。
J Allergy Clin Immunol. 2010 Mar;125(3):676-82. doi: 10.1016/j.jaci.2009.11.047.
7
The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber.比利司他与西替利嗪、非索非那定和安慰剂在维也纳挑战舱中暴露于气传变应原的患者中对变应原诱导的鼻和眼部症状的影响。
Inflamm Res. 2010 May;59(5):391-8. doi: 10.1007/s00011-009-0117-4. Epub 2009 Nov 27.
8
Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study.比较比利司特 20 毫克与左西替利嗪 5 毫克治疗慢性特发性荨麻疹的疗效和安全性：一项多中心、双盲、随机、安慰剂对照研究。
Allergy. 2010 Apr;65(4):516-28. doi: 10.1111/j.1398-9995.2009.02217.x. Epub 2009 Oct 23.
9
Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.20毫克比拉斯汀与10毫克西替利嗪及安慰剂用于季节性变应性鼻炎症状治疗的疗效和安全性：一项随机、双盲、平行组研究
Clin Exp Allergy. 2009 Sep;39(9):1338-47. doi: 10.1111/j.1365-2222.2009.03257.x. Epub 2009 May 4.
10
Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients.20毫克比拉斯汀与5毫克地氯雷他定治疗季节性变应性鼻炎患者的疗效和安全性比较。
Allergy. 2009 Jan;64(1):158-65. doi: 10.1111/j.1398-9995.2008.01813.x.
Zotero 插件